Abstract

Breast cancer and HIV coexistence presents a challenging medical landscape, necessitating a thorough exploration of hematologic considerations and blood transfusion strategies. This review delves into the intricate interplay of anemia, thrombocytopenia, neutropenia, and coagulopathy in breast cancer patients with HIV, offering insights into the management of these hematologic complications. Additionally, the article highlights key elements of blood transfusion strategies, treatment impacts, and infection risk mitigation in this unique patient population. A comprehensive understanding of these hematologic aspects is crucial for tailoring effective and patient-centered care, ultimately improving outcomes and enhancing the quality of life for individuals facing the dual burden of breast cancer and HIV